No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study
- 28 February 2001
- journal article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 11 (1), 69-74
- https://doi.org/10.1016/s0924-977x(00)00134-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tourette's syndromeNeurology, 1998
- The Dopamine Transporter Protein Gene (SLC6A3): Primary Linkage Mapping and Linkage Studies in Tourette SyndromeGenomics, 1995
- Tourette's syndrome. A model neuropsychiatric disorderPublished by American Medical Association (AMA) ,1995
- Dopamine receptor availability in Tourette's syndromePsychiatry Research: Neuroimaging, 1994
- Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brainSynapse, 1994
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: A 99Tcm-HMPAO SPECT studyPsychiatry Research: Neuroimaging, 1992
- The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disordersPublished by American Medical Association (AMA) ,1991
- Untying the Gordian Knot: The Genetics of Tourette SyndromeThe Journal of Nervous and Mental Disease, 1990
- The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic SeverityJournal of the American Academy of Child & Adolescent Psychiatry, 1989